Lipid-lowering drugs and essential hemorrhagic thrombocythemia's risk: A drug-target Mendelian randomization study. [PDF]
Zhang P +8 more
europepmc +1 more source
Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis. [PDF]
Guo P, Yu X, Wei X, Xiong X, Jiang J.
europepmc +1 more source
Emerging insights into the role of BDH1 in the pathogenesis of human cancer. [PDF]
Wang P, Yan Y, Liu Z, Feng G, Yu W.
europepmc +1 more source
Causal effects of lipid-lowering drug targets on psychiatric disorders: A drug-target Mendelian randomization study. [PDF]
Wang Y, Liu X, Huang S.
europepmc +1 more source
Computational Evaluation of Statin Analogs Targeting HMG-CoA Reductase for Coronary Artery Disease Treatment. [PDF]
Mtulo YB +4 more
europepmc +1 more source
Statins and Fibrates in Age-Related Macular Degeneration: A Contemporary Clinical Narrative Review (2020-2025). [PDF]
Dmoch W +5 more
europepmc +1 more source
Natural products as HMG-CoA reductase inhibitors (statins) for the management of non-communicable diseases. [PDF]
Muhammad RN +12 more
europepmc +1 more source
Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]
Chitsazi MR +9 more
europepmc +1 more source
Increasing recognition of statin-associated anti-HMGCR antibody-positive autoimmune myopathy: a single-center retrospective study. [PDF]
Mali M +4 more
europepmc +1 more source

